Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)

v3.24.4
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Deferred tax assets:      
Net operating loss carryforwards $ 21,553,000 $ 20,941,000 $ 20,780,000
Research and development credit carryforward 27,000 27,000 27,000
Capitalized research and development expenses 1,987,000 1,320,000
Stock compensation 638,000 971,000 1,636,000
Disallowed interest expense 431,000
Lease liability 567,000 736,000 802,000
Other, net 1,785,000 1,366,000 943,000
Gross deferred tax assets 26,988,000 25,361,000 24,188,000
Less valuation allowance (26,483,000) (24,696,000) (23,461,000)
Total deferred tax assets 505,000 665,000 727,000
Deferred tax liabilities:      
Right of use asset (505,000) (665,000) (727,000)
Total deferred tax liabilities (505,000) (665,000) (727,000)
Total net deferred tax liabilities